Tissue engineering: autologous full- thickness skin substitute for healing chronic wounds A. Bellomi, G. Calabrese, A. Cassisa, F. Colpani, R. Fante, L.

Slides:

Advertisements

Similar presentations

$100 $400 $300$200$400 $200$100$100$400 $200$200$500 $500$300 $200$500 $100$300$100$300 $500$300$400$400$500.

Advertisements

Integumentary Status OASIS-C Contact: Cindy Skogen, RN (OEC)

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

$100 $200 $300 $400 $100 $200 $300 $400 $100 $200 $300 $400 $100 $200 $300 $400 $100 $200 $300 $400.

Medical Biotechnology Regenerative Medicine

Created by Susan Neal $100 Fractions Addition Fractions Subtraction Fractions Multiplication Fractions Division General $200 $300 $400 $500 $100 $200.

Circulation E Welcome!. Case 71  Clinical: female aged 65 years - lesion on extensor aspect of right elbow  Specimen: Biopsy of lesion.  Macro: Multiple.

AAWC Venous Ulcer Guideline

Oxygen therapy venous stasis ulcers and devitalised tissues in the lower limbs District Madeyski Hyperbaric Chamber 2003.

The Prevalence of Foot Ulceration in Rheumatoid Arthritis The Prevalence of Foot Ulceration in Rheumatoid Arthritis Jill Firth 1, Claire Hale 1, Philip.

Immediate management of the obstetric fistula kees waaldijk MD PhD babbar ruga fistula teaching hospital.

Paul Whiting M. D. and Daniel Galat M. D

Investigation of diabetic patients with chronic ulcers in the lower limb Non-healing wounds >2 months Biopsi from wond margin for biomarker analysis, stored.

Clinical Case Reports David Gray Clinical Nurse Specialist On behalf of Department of Tissue Viability Grampian Health Services Aberdeen.

BY DR.Surapol chagkornburee

© CellTran Limited TM Stem Cell Research and Tissue Engineering Sheila Mac Neil Professor Of Tissue Engineering and founder Director of Celltran Ltd Ethical.

Ortec International, Inc. Developing Innovative Products To Advance Regenerative Medicine.

Leg Ulcers. Introduction Define Leg ulcer Introduce the scenario Identify the main causes and conditions Assessment and planning of scenario Discuss the.

Introduction Verrucous carcinoma is a form of well-differentiated squamous cell carcinoma. The recognized clinical subtypes of verrucous carcinoma are:

USE OF A NEW ULCER CLEANSING SYSTEM AND OF PLATELET GEL IN THE MANAGEMENT OF “NON HEALING” LEG ULCERS IN ELDERLY PALUMBO F.P. 1 – SERANTONI S. 2 – ABBRITTI.

Biological and Physiological Effects of Laser Therapy Treatment

Exploring The Impact of Wound Complications Upon the Lives of Patients.

Calciphylaxis Induced Ulcerations. John M. Lavelle, 1 DO; Paul Liguori MD 2 1. Boston University Medical Center, Rehabilitation Department 2. Whittier.

VENOUS STASIS ULCERS. Venous stasis ulcer: occurs from chronic deep vein insufficiency and stasis of blood in the venous system of the legs An open, necrotic.

VISN 11 Wound Care Teleconsultation Program Julie Lowery, PhD Implementation Research Coordinator Leah Gillon, MSW Administrative Coordinator Diabetes.

Artificial Skin Vi Tran Section 1 October 23,2013 Vi Tran BME 281.

CHRONIC WOUND TREATMENT. WHAT IS A WOUND AND HOW DOES OUR BODY REACT TO IT???????

Organogenesis Canton, MA Since 1985 First company to gain FDA approval for a “living skin” product: Apligraf® Approved for treatment of diabetic foot ulcers.

Wounds Research for Patient Benefit funded by the.

Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.

Botryomycosis Staphylococcosis.

 Head and neck cancer is the 6 th leading cancer world wide.  Oral Mucositis is one of the most frequent complications seen in the treatment of head.

Introduction The repair of an epithelial wound is merely a normal physiological process. Wound healing depends on elimination of any source of infection.

Pediatric Burns.

MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.

SKIN EPIDERMI S DERMIS.

Cultured in vitro human autologous epidermis for clinical applications Justyna Drukała Laboratory of Cell and Tissue Engineering Department of Cell.

Use of antimicrobial dressings Fran Whitehurst Clinical Nurse Specialist in Tissue Viability Conwy and Denbighshire NHS Trust.

1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.

Bill Marston, MD Professor and Chief, Division of Vascular Surgery

Volume 15, Issue 3, Pages (March 2007)

Cell Suspensions of Autologous Keratinocytes or Autologous Fibroblasts Accelerate the Healing of Full Thickness Skin Wounds in a Diabetic Porcine Wound.

Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans Serkan Durdu, MD, Ahmet Ruchan.

Case Study: Surgical Wound

Surgical Management of Diabetic Foot Infections and Amputations

The cell based dressing with living allogenic keratinocytes in the treatment of foot ulcers: a case study Yalcin Bayram, Mustafa Deveci, Nejat Imirzalioglu,

Prognosis of younger patients in non-small cell lung cancer

SYSTEMIC POLYMORPHONUCLEAR COUNT

What is PHLEBOLOGY?. What is PHLEBOLOGY? Anatomy review Deep vein system vs. Superficial vein system.

Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings Margaret A. Fonder, BS, Gerald S. Lazarus,

Skin Grafts and tissue flaps

Clinical Microbiology and Infection

Manabu Ohyama, Hideyuki Okano Journal of Investigative Dermatology

Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers Eugenio Brizzio, MD, Felix Amsler, MS,

Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers Eugenio Brizzio, MD, Felix Amsler, MS,

Jasper G. van den Boorn, Debby Konijnenberg, Trees A. M. Dellemijn, J

The cell based dressing with living allogenic keratinocytes in the treatment of foot ulcers: a case study Yalcin Bayram, Mustafa Deveci, Nejat Imirzalioglu,

Advanced Biology Burns Skin Cancer.

Combined treatment with compression therapy and ablation of incompetent superficial and perforating veins reduces ulcer recurrence in patients with CEAP.

Mohammad Rashel, Ninche Alston, Soosan Ghazizadeh

Dan F. Spandau, Davina A. Lewis, Ally-Khan Somani, Jeffrey B. Travers

Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept

Cultured allogeneic fibroblast injection versus fibroblasts cultured on amniotic membrane scaffold for dystrophic epidermolysis bullosa treatment Moravvej.

TEMPLATE Picture Picture Picture Picture Picture Picture Picture

Activin overexpression leads to keratinocytic cysts and high cell density in the granulation tissue of healed wounds. Activin overexpression leads to keratinocytic.

Role of TGFβ-Mediated Inflammation in Cutaneous Wound Healing

Gerry Rayman Prashanth Vas Ketan Dhatariya Vicki Driver

Presentation transcript:

Tissue engineering: autologous full- thickness skin substitute for healing chronic wounds A. Bellomi, G. Calabrese, A. Cassisa, F. Colpani, R. Fante, L. Gaetti, G. Granchelli, S. Negri Servizio Anatomia Patologica Ospedale C. Poma – Mantova

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Chronic wounds, inclouding venous and arteriosclerotic leg ulcers, diabetic foot ulcers, decubitus and trauma induced wounds, represent a major problem in our society. These wounds occur with high incidence and exist for prolonged periods of time and therefore have a great socioeconomic impact. The problem increases as the average age of the population increases and therefore new therapies in wound healing are continously being sought. The aim of this study is to develop an autologous, full-thickness skin substitute and to evaluate its efficiency and applicability in closing long-standing ulcers that have proven non-responsive to the currently available wound-healing therapies (topical therapy, antibiotic treatment, surgical debridment, external compression). Introduction

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Method We included 20 patients with long-standing ulcers of which 13 venous and arteriosclerotic (65%), 3 diabetic (15%), 3 trauma-induced and 1 burn wounds (5%). Age of patients varies from 57 to 91 (average 75). The lesions were present since at least two years. A single punch biopsy (diameter cm 0,6) or a surgical biopsy (cm 1,5x1) obtained from the patients upper leg were required. After 3-4 weeks we obtaneid three autologous products on collagen support (Antema soft, Opocrin S.P.A): fibroblasts (fig.1 ), fibroblasts and keratinocytes (fig.2 ) and keratinocytes (fig.3 ). Sheets of keratinocytes present basal melanocytes (fig.4 ); between keratinocytes and fibroblasts we observe basement membrane ( fig.5 ). Depending on ulcers depth and dimensions our patients underwent multiple applications (at least two). All procedures were performed with the Ethics Committee approval and patient consent.

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Fig.1: haematoxylin-eosin stain (200x)

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Fig.2: haematoxylin-eosin stain (400x)

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Fig.3: haematoxylin-eosin stain (400x)

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Fig. 4: immunohistochemical detection of basement membrane - collagen IV- 400 x

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Fig. 5: immunohistochemical detection of melanocytes - HMB x

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma The success rate in culturing biopsies was 100%. The skin substitute visibly resembled an autograft. Ten of the 13 (77%) chronic venous ulcers (size cmq) healed between 8 and 48 weeks (case 1 and 2). One of the 3 (33%) diabetic ulcers (size 3-28 cmq) healed within 12 weeks. Three (100%) trauma induced ulcers (size 4-6 cmq) healed between 6 and 12 weeks. One (100%) burn ulcer (size 12 cmq) healed within 4 weeks. Skin substitutes were very well tollerated and pain relief was immediate after application. Results

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Female 80 years old, with vascular ulcer since three years non responsive to the currently available therapies... Case n° 1 Female 80 years old, with vascular ulcer since three years non responsive to the currently available therapies...

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma The same woman after autologous full-thicness skin substitute application Case n° 1 The same woman after autologous full-thicness skin substitute application

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma Female 73 years old, with vascular ulcer since two years non responsive to the currently available therapies... Case n° 2 Female 73 years old, with vascular ulcer since two years non responsive to the currently available therapies...

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma The same woman after autologous full-thicness skin substitute application Case n° 2 The same woman after autologous full-thicness skin substitute application

Anatomia Patologica, Mantova. Az. Ospedaliera C.Poma The application of this noval skin sobstitute provides a promising new therapy for healing chronic wounds resistant to conventional therapies. It is also necessary to point out the importance of suitable cyto-histological and immunohistochemical studies for evaluating the correct cell morphology and phenotype. Conclusion